Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neuritin 1 (NRN1) is a GPI-anchored neuronal protein encoded by the NRN1 gene, primarily expressed in postmitotic-differentiating neurons during development and adult brain regions involved in plasticity[1][3][6]. Its expression is regulated by neural activity and neurotrophins. The protein promotes neurite outgrowth and branching, supporting neuritogenesis and synaptic plasticity[1][6]. Overexpression of Neuritin 1 is implicated in astrocytoma progression, and it is involved in metabolic regulation within brown adipocytes[4]. Alternative splicing produces multiple transcript variants. NRN1 is not classified as a conventional receptor or enzyme but is considered a therapeutic target due to its roles in neural and metabolic function[1][2][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neuritin 1 (NRN1).